USF Asthma Allergy and Immunology Clinical Research Unit
Welcome,         Profile    Billing    Logout  
 7 Trials 
21 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Casale, Thomas
PREPARED-1, NCT06339008: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis

Recruiting
3
450
Europe, US, RoW
LY3650150, Placebo, Standard therapy for INCS
Eli Lilly and Company
Perennial Allergic Rhinitis (PAR)
10/25
02/27
NCT04430179: Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

Recruiting
2
30
US
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], Placebo
University of South Florida
Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
07/23
12/23
NCT05363670: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Completed
2
18
US
ARS-1, Albuterol MDI, Placebo
ARS Pharmaceuticals, Inc.
Asthma
02/24
02/24
CALM-CSU, NCT06077773: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Terminated
2
113
Europe, Canada, US
Oral EP262, Placebo
Escient Pharmaceuticals, Inc
Chronic Spontaneous Urticaria
12/24
01/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Pesek, Robbie D
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Sindher, Sayantani
MOTIF, NCT03504774: Food Allergen OIT for Shrimp and Cashew

Terminated
2
58
US
Cashew or Shrimp Oral Immunotherapy, OIT
Sayantani B. Sindher, National Institute of Allergy and Infectious Diseases (NIAID)
Allergy;Food, Allergy to Shrimp, Allergy to Cashew Nut (Disorder)
01/23
03/23
NCT03679676: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

Active, not recruiting
2
108
US
Omalizumab, Xolair, Dupilumab, Dupixent, Placebo
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education, Harvard School of Public Health (HSPH)
Hypersensitivity, Food Allergy, Hypersensitivity, Food, Peanut Hypersensitivity, Peanut Allergy
04/25
09/25
NCT03742414: Seal, Stopping Eczema and Allergy Study

Recruiting
2
312
Europe, US
Tri-lipid skin barrier cream (Epiceram), Fluticasone propionate Cream 0.05%, Standard of Care
Kari Nadeau, MD, PhD, National Jewish Health, University of Chicago, Children's Hospital Medical Center, Cincinnati, Harvard School of Public Health (HSPH), Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), King's College London, Guy's and St Thomas' NHS Foundation Trust
Eczema, Infantile, Eczema, Atopic Dermatitis Eczema, Atopic Dermatitis
05/28
06/28
NCT04148352: Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy

Terminated
2
33
US
Dupilumab, Placebo
Andrew J Long, PharmD, Robert Levin Charitable Fund, Regeneron Pharmaceuticals
Allergies Food Milk
12/24
02/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
NCT04579588: Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Recruiting
N/A
230
US
Flu shot
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID)
Corona Virus Infection, Flu Vaccine, Immunity
03/26
03/26
NCT04376242: Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge

Recruiting
N/A
140
US
use of virtual reality, use of standard technology
Stanford University
Food Allergy in Children, Food Allergy
09/25
09/25
Prescreen, NCT03539692: ing Protocol to Enroll in Food Allergy Clinical Studies at a Single Site

Recruiting
N/A
1000
US
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Food Allergy
12/26
12/26
Garcia-Lloret, Maria
NCT03679676: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

Active, not recruiting
2
108
US
Omalizumab, Xolair, Dupilumab, Dupixent, Placebo
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education, Harvard School of Public Health (HSPH)
Hypersensitivity, Food Allergy, Hypersensitivity, Food, Peanut Hypersensitivity, Peanut Allergy
04/25
09/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
adored, NCT05003804: Allergic Disease Onset Prevention Study

Active, not recruiting
1/2
264
US, RoW
STMC-103H, Placebo
Siolta Therapeutics, Inc.
Atopic Dermatitis, Type 1 Hypersensitivity
11/24
10/25
Currie, Kristen
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Orden, Roy
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Twitmyer, Patricia Michelle
NCT05976243: A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Recruiting
3
348
Europe, Canada, Japan, US, RoW
Remibrutinib, Placebo
Novartis Pharmaceuticals
Chronic Inducible Urticaria
03/26
12/28
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Casale, Thomas
PREPARED-1, NCT06339008: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis

Recruiting
3
450
Europe, US, RoW
LY3650150, Placebo, Standard therapy for INCS
Eli Lilly and Company
Perennial Allergic Rhinitis (PAR)
10/25
02/27
NCT04430179: Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

Recruiting
2
30
US
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], Placebo
University of South Florida
Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
07/23
12/23
NCT05363670: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Completed
2
18
US
ARS-1, Albuterol MDI, Placebo
ARS Pharmaceuticals, Inc.
Asthma
02/24
02/24
CALM-CSU, NCT06077773: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Terminated
2
113
Europe, Canada, US
Oral EP262, Placebo
Escient Pharmaceuticals, Inc
Chronic Spontaneous Urticaria
12/24
01/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Pesek, Robbie D
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Sindher, Sayantani
MOTIF, NCT03504774: Food Allergen OIT for Shrimp and Cashew

Terminated
2
58
US
Cashew or Shrimp Oral Immunotherapy, OIT
Sayantani B. Sindher, National Institute of Allergy and Infectious Diseases (NIAID)
Allergy;Food, Allergy to Shrimp, Allergy to Cashew Nut (Disorder)
01/23
03/23
NCT03679676: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

Active, not recruiting
2
108
US
Omalizumab, Xolair, Dupilumab, Dupixent, Placebo
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education, Harvard School of Public Health (HSPH)
Hypersensitivity, Food Allergy, Hypersensitivity, Food, Peanut Hypersensitivity, Peanut Allergy
04/25
09/25
NCT03742414: Seal, Stopping Eczema and Allergy Study

Recruiting
2
312
Europe, US
Tri-lipid skin barrier cream (Epiceram), Fluticasone propionate Cream 0.05%, Standard of Care
Kari Nadeau, MD, PhD, National Jewish Health, University of Chicago, Children's Hospital Medical Center, Cincinnati, Harvard School of Public Health (HSPH), Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), King's College London, Guy's and St Thomas' NHS Foundation Trust
Eczema, Infantile, Eczema, Atopic Dermatitis Eczema, Atopic Dermatitis
05/28
06/28
NCT04148352: Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy

Terminated
2
33
US
Dupilumab, Placebo
Andrew J Long, PharmD, Robert Levin Charitable Fund, Regeneron Pharmaceuticals
Allergies Food Milk
12/24
02/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
NCT04579588: Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Recruiting
N/A
230
US
Flu shot
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID)
Corona Virus Infection, Flu Vaccine, Immunity
03/26
03/26
NCT04376242: Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge

Recruiting
N/A
140
US
use of virtual reality, use of standard technology
Stanford University
Food Allergy in Children, Food Allergy
09/25
09/25
Prescreen, NCT03539692: ing Protocol to Enroll in Food Allergy Clinical Studies at a Single Site

Recruiting
N/A
1000
US
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Food Allergy
12/26
12/26
Garcia-Lloret, Maria
NCT03679676: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

Active, not recruiting
2
108
US
Omalizumab, Xolair, Dupilumab, Dupixent, Placebo
Stanford University, National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education, Harvard School of Public Health (HSPH)
Hypersensitivity, Food Allergy, Hypersensitivity, Food, Peanut Hypersensitivity, Peanut Allergy
04/25
09/25
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
adored, NCT05003804: Allergic Disease Onset Prevention Study

Active, not recruiting
1/2
264
US, RoW
STMC-103H, Placebo
Siolta Therapeutics, Inc.
Atopic Dermatitis, Type 1 Hypersensitivity
11/24
10/25
Currie, Kristen
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Orden, Roy
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26
Twitmyer, Patricia Michelle
NCT05976243: A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Recruiting
3
348
Europe, Canada, Japan, US, RoW
Remibrutinib, Placebo
Novartis Pharmaceuticals
Chronic Inducible Urticaria
03/26
12/28
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting
1/2
192
Canada, US
Peanut SLIT-tablet, Placebo
ALK-Abelló A/S, Parexel
Peanut Allergy
01/26
02/26

Download Options